Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9181492rdf:typepubmed:Citationlld:pubmed
pubmed-article:9181492lifeskim:mentionsumls-concept:C0015780lld:lifeskim
pubmed-article:9181492lifeskim:mentionsumls-concept:C1882598lld:lifeskim
pubmed-article:9181492lifeskim:mentionsumls-concept:C0033306lld:lifeskim
pubmed-article:9181492lifeskim:mentionsumls-concept:C0178601lld:lifeskim
pubmed-article:9181492lifeskim:mentionsumls-concept:C0597879lld:lifeskim
pubmed-article:9181492lifeskim:mentionsumls-concept:C0205146lld:lifeskim
pubmed-article:9181492lifeskim:mentionsumls-concept:C0205263lld:lifeskim
pubmed-article:9181492lifeskim:mentionsumls-concept:C0037239lld:lifeskim
pubmed-article:9181492pubmed:issue5lld:pubmed
pubmed-article:9181492pubmed:dateCreated1997-7-30lld:pubmed
pubmed-article:9181492pubmed:abstractTextInjection of dopamine or dopamine receptor subtype agonists facilitates the expression of lordosis in estrogen-primed female rats. The D1 receptor specific agonist, SKF-38393, facilitates lordosis in estradiol-primed female rats via a process that requires progestin receptors. Based on these data, neuronal response to the D1 receptor agonist SKF-38393 was assessed by expression of the immediate early gene protein, Fos. In the first experiment we examined the modulation of Fos expression by D1 agonists in progestin receptor-containing areas of estradiol-primed female rat brain. In the second experiment we examined if there are progestin if there are progestin receptor-containing cells that respond to stimulation of D1 receptors with increased Fos expression. Ten to 14 days following ovariectomy and stereotaxic surgery, animals were injected with 5 micrograms estradiol benzoate. Forty eight h later they were injected intracerebroventricularly with 100 ng of SKF-38393 or saline. One h following injection animals were perfused, and brain sections immunostained for Fos protein. Results from the first experiment suggest that SKF-38393 increased the total number of Fos immunoreactive cells in the mid-ventromedial hypothalamic nucleus/ventrolateral portion (VMHVL), the caudal VMHVL, the paraventricular hypothalamic nucleus and the caudate putamen. In the medial preoptic area, the rostral VMHVL and the arcuate hypothalamic nucleus, there was a significant increase in the number of darkly stained Fos-immunoreactive cells following the SKF-38393 treatment. In the second study, SKF-38393 increased the number of progestin receptor-containing cells which contained Fos immunoreactivity in the caudal VMHVL. The results suggest potential sites of action for the facilitation of sexual behavior by centrally administered D1 agonists.lld:pubmed
pubmed-article:9181492pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9181492pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9181492pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9181492pubmed:languageenglld:pubmed
pubmed-article:9181492pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9181492pubmed:citationSubsetIMlld:pubmed
pubmed-article:9181492pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9181492pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9181492pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9181492pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9181492pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9181492pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9181492pubmed:statusMEDLINElld:pubmed
pubmed-article:9181492pubmed:monthMaylld:pubmed
pubmed-article:9181492pubmed:issn0953-8194lld:pubmed
pubmed-article:9181492pubmed:authorpubmed-author:BlausteinJ...lld:pubmed
pubmed-article:9181492pubmed:authorpubmed-author:MeredithJ MJMlld:pubmed
pubmed-article:9181492pubmed:authorpubmed-author:AugerA PAPlld:pubmed
pubmed-article:9181492pubmed:issnTypePrintlld:pubmed
pubmed-article:9181492pubmed:volume9lld:pubmed
pubmed-article:9181492pubmed:ownerNLMlld:pubmed
pubmed-article:9181492pubmed:authorsCompleteYlld:pubmed
pubmed-article:9181492pubmed:pagination385-94lld:pubmed
pubmed-article:9181492pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:9181492pubmed:meshHeadingpubmed-meshheading:9181492-...lld:pubmed
pubmed-article:9181492pubmed:meshHeadingpubmed-meshheading:9181492-...lld:pubmed
pubmed-article:9181492pubmed:meshHeadingpubmed-meshheading:9181492-...lld:pubmed
pubmed-article:9181492pubmed:meshHeadingpubmed-meshheading:9181492-...lld:pubmed
pubmed-article:9181492pubmed:meshHeadingpubmed-meshheading:9181492-...lld:pubmed
pubmed-article:9181492pubmed:meshHeadingpubmed-meshheading:9181492-...lld:pubmed
pubmed-article:9181492pubmed:meshHeadingpubmed-meshheading:9181492-...lld:pubmed
pubmed-article:9181492pubmed:meshHeadingpubmed-meshheading:9181492-...lld:pubmed
pubmed-article:9181492pubmed:meshHeadingpubmed-meshheading:9181492-...lld:pubmed
pubmed-article:9181492pubmed:meshHeadingpubmed-meshheading:9181492-...lld:pubmed
pubmed-article:9181492pubmed:meshHeadingpubmed-meshheading:9181492-...lld:pubmed
pubmed-article:9181492pubmed:meshHeadingpubmed-meshheading:9181492-...lld:pubmed
pubmed-article:9181492pubmed:meshHeadingpubmed-meshheading:9181492-...lld:pubmed
pubmed-article:9181492pubmed:year1997lld:pubmed
pubmed-article:9181492pubmed:articleTitleD1 dopamine receptor agonist (SKF-38393) induction of Fos immunoreactivity in progestin receptor-containing areas of female rat brain.lld:pubmed
pubmed-article:9181492pubmed:affiliationPsychology Department, University of Massachusetts, Amherst 01003, USA.lld:pubmed
pubmed-article:9181492pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9181492pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9181492lld:pubmed